... Remember, receiving a proper diagnosis is an important first step toward accessing the care and support you need. ...
... Healthcare Services as an Undocumented Immigrant: Practical Tips — Center for Human Rights and Constitutional Law Patient Assistance Programs and Co-Payment Assistance Programs: Resources for Accessing HIV Treatment — HIV.gov Patient Assistance Programs and Co-Payment Assistance Programs: Resources for Accessing HIV Treatment (FAQs) — HIV.gov Noncitizens ...
5 Programs To Assist Undocumented Immigrants Who Have HIV
... Healthcare Services as an Undocumented Immigrant: Practical Tips — Center for Human Rights and Constitutional Law Patient Assistance Programs and Co-Payment Assistance Programs: Resources for Accessing HIV Treatment — HIV.gov Patient Assistance Programs and Co-Payment Assistance Programs: Resources for Accessing HIV Treatment (FAQs) — HIV.gov Noncitizens ...
... Antiretroviral Therapy in Europe and North America: A Collaborative Analysis of Cohort Studies — The Lancet Defining Comorbidity: Implications for Understanding Health and Health Services — Annals of Family Medicine HIV Therapy, Metabolic Syndrome, and Cardiovascular Risk — Current Atherosclerosis Reports Excess Clinical Comorbidity Among HIV-Infected Patients Accessing ...
Aging With HIV: 5 Problems To Watch For
... Antiretroviral Therapy in Europe and North America: A Collaborative Analysis of Cohort Studies — The Lancet Defining Comorbidity: Implications for Understanding Health and Health Services — Annals of Family Medicine HIV Therapy, Metabolic Syndrome, and Cardiovascular Risk — Current Atherosclerosis Reports Excess Clinical Comorbidity Among HIV-Infected Patients Accessing ...
... Stigma from yourself and from others can prevent you from accessing necessary HIV services or using strategies to prevent the spread of HIV.If you feel comfortable, share your story with others to humanize the experience of living with HIV and dispel misconceptions. ...
... If you want more information about your potential risk, you can start by accessing the CDC’s HIV Risk Reduction Tool. Keep in mind that only a medical provider familiar with your case can offer advice specific to your own life circumstances.3. ...
5 Reasons Straight People Should Talk About PrEP
... If you want more information about your potential risk, you can start by accessing the CDC’s HIV Risk Reduction Tool. Keep in mind that only a medical provider familiar with your case can offer advice specific to your own life circumstances.3. ...
... Researchers found that 96 percent of people taking the new treatment maintained an undetectable viral load after 48 weeks, compared with 92 percent of people who stayed on their previous regimen.What Are the Potential Side Effects? ...
FDA Approves Once-Daily, 2-Drug Pill for HIV Treatment
... Researchers found that 96 percent of people taking the new treatment maintained an undetectable viral load after 48 weeks, compared with 92 percent of people who stayed on their previous regimen.What Are the Potential Side Effects? ...
... This was compared to a control group, which is a set of people who didn’t fast or receive the treatment being tested, to provide a starting point for measuring the effects of fasting.High-sensitivity C-reactive protein (hs-CRP) is a sign in your blood that shows there is inflammation and may show a higher risk of heart disease. ...
Fasting and HIV: Can It Help?
... This was compared to a control group, which is a set of people who didn’t fast or receive the treatment being tested, to provide a starting point for measuring the effects of fasting.High-sensitivity C-reactive protein (hs-CRP) is a sign in your blood that shows there is inflammation and may show a higher risk of heart disease. ...
... In four studies that led to its approval, Spravato performed well against placebo, the FDA said, showing a "statistically significant effect compared to placebo on the severity of depression, and some effect was seen within two days." ...
FDA Approves Ketamine-Like Drug for Severe Depression
... In four studies that led to its approval, Spravato performed well against placebo, the FDA said, showing a "statistically significant effect compared to placebo on the severity of depression, and some effect was seen within two days." ...
... Cancers commonly associated with HIV include: Lymphoma, a cancer in white blood cells Kaposi’s sarcoma, which causes tumors on the walls of blood vessels Cancers caused by HPV, a virus that can cause throat or cervical cancer, as well as other types of genital cancers Importantly, even people with well-managed HIV can still face higher cancer risks compared ...
6 Complications of HIV You Must Know About
... Cancers commonly associated with HIV include: Lymphoma, a cancer in white blood cells Kaposi’s sarcoma, which causes tumors on the walls of blood vessels Cancers caused by HPV, a virus that can cause throat or cervical cancer, as well as other types of genital cancers Importantly, even people with well-managed HIV can still face higher cancer risks compared ...
... The lower chance of spreading HIV-2 might be due to its lower virus levels in people with HIV-2 compared to those with HIV-1. For example, untreated mothers with HIV-1 have a 15 percent to 30 percent chance of transmitting the virus to their child during pregnancy or birth. ...
HIV-1 vs. HIV-2: What Are The Differences and Can You Have Both?
... The lower chance of spreading HIV-2 might be due to its lower virus levels in people with HIV-2 compared to those with HIV-1. For example, untreated mothers with HIV-1 have a 15 percent to 30 percent chance of transmitting the virus to their child during pregnancy or birth. ...
Join
Your Privacy Choices
